Condition
Diabetic Retinopathy (DR) clinical trials and research
As of November 12, 2026, Find a Trial lists 15 Diabetic Retinopathy (DR) clinical trials that are recruiting, at sites in 9 countries (most in Bangladesh (3), United States (3), Taiwan (2)). By phase: Phase 4 (1). The most active sponsors are National Taiwan University Hospital (2), Orbis (2). There are also 1 NIH-funded research project on Diabetic Retinopathy (DR), with $441,907 in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 15Clinical trials
- 1NIH research projects
- 9Countries
Newest Diabetic Retinopathy (DR) clinical trials
All recruiting trials (15)
-
Automated AI system to detect diabetic retinopathy in adults with diabetes
A AI-based software device is being tested to automatically detect diabetic retinopathy from retinal images in adults with diabetes.
-
N-acetylcysteine for diabetic retinopathy in adults with type 2 diabetes
This study tests whether taking N-acetylcysteine for three months can help people with type 2 diabetes who have mild to moderate diabetic retinopathy.
-
Early imaging changes with faricimab versus biosimilar ranibizumab for diabetic retinal disease
This trial will see if faricimab or a biosimilar ranibizumab causes different early OCT and OCTA imaging changes in adults with diabetic retinopathy or diabetic macular edema who need anti-VEGF injections.
-
Finding protein biomarkers for AMD, diabetic retinopathy, and retinal detachment
This project will test whether proteins found in blood and eye fluids can help diagnose or predict outcomes for adults with AMD, diabetic retinopathy, or retinal detachment.
-
Diabetic retinopathy prevalence and risk factors at a Da Nang hospital
We will find how common different stages of diabetic retinopathy are and which clinical or lab factors are linked to it among adults with diabetes treated at a Da Nang hospital.
-
AI-assisted retinal photo screening for adults with diabetes
This will test whether adding the VUNO Med®-Fundus AI tool to routine retinal photo screening helps adults with type 2 diabetes get more accurate referrals for diabetic retinopathy.
-
New-generation diabetes medicines and the onset of diabetic retinopathy
This study will test whether newer diabetes medicines (SGLT2 and DPP‑4 inhibitors) can delay diabetic retinopathy in people with type 2 diabetes who've had the disease for more than five years and have been on diabetes medications for 2–3 years.
-
PRONTO-EYE rideshare program to help people with diabetic retinopathy get to eye appointments
This project tests whether a rideshare transportation program (PRONTO‑EYE) helps people with diabetic retinopathy who have Medicaid get to ophthalmology appointments more often.
-
DRISTi AI screening for diabetic retinopathy
This will test whether the DRISTi artificial-intelligence software can correctly detect diabetic retinopathy from retinal photos in adults with diabetes.
-
My Eyes, My Light — community eye screening in Char Fasson
This project tests whether a community-based screening program can find treatable eye problems in people aged 35 and older who live in Char Fasson, Bangladesh.
-
AI-assisted eye screening for diabetic retinopathy and age-related macular degeneration in outpatient clinics
This project will test whether the VeriSee AI software helps doctors find diabetic eye disease and macular degeneration earlier in adults with diabetes or people aged 50 and older.
-
Using eye exam results to guide diabetes care for people with diabetic retinopathy in Dinajpur
This project will try sending specific diabetes management recommendations based on patients' eye exams to diabetes doctors to see if people with diabetes and diabetic retinopathy reach WHO blood sugar targets more often.
-
Using voice reminders and free reading glasses to boost diabetes eye care in Dinajpur, Bangladesh
This project will test whether automated voice-message reminders that talk about vision-loss risk, combined with free reading glasses, help people with diabetes in Dinajpur, Bangladesh keep their diabetes and eye appointments and get better patient-centered care.
-
Investigating metabolic and lipid profiles in diabetic eye disease
This study is trying to see how blood and urine samples from people with diabetes relate to eye damage caused by diabetic eye disease and if gut bacteria play a role in this.
-
VeriSee AI for screening macular degeneration and diabetic retinopathy
This trial will test whether the VeriSee AI software can help doctors screen for age-related macular degeneration in adults 50+ and diabetic retinopathy in diabetic adults 20+.
NIH-funded research (1)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Finding Early Signs of Diabetic Eye Damage
This project is developing a new way to find early signs of eye damage from diabetes, even before vision problems start.
Related topics
Quick answers
How many Diabetic Retinopathy (DR) clinical trials are recruiting right now?
15, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 9 countries. The most sites are in Bangladesh (3 trials), United States (3 trials), Taiwan (2 trials), Egypt (2 trials), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.